Medical Degree, Faculty of Medicine, National and Kapodistrian University of Athens
2001 - 2004: Intern Pediatrician, University Hospital of Patras
2004 - 2007: Specialty training in Pediatric Endocrinology (Clinical Fellow in Pediatric Endocrinology, Division of Pediatric Endocrinology, Department of Pediatrics, Miller School of Medicine/Jackson Memorial Hospital, University of Miami, FL, USA) and Pediatric Diabetes (Diabetes Research Institute, Miller School of Medicine, University of Miami, 2007 - 2008)
1996 - currently: Member, Athens Medical Association
2004 - currently: Member, Endocrine Society
2009: PhD, Medical School, University of Thessaly, grade summa cum laude
2013 - currently: Member, Hellenic Society for Pediatric and Adolescent Endocrinology
2014 - currently: Pediatric Endocrinology Lecturer, Medical School, University of Thessaly
Publications in International Journals
HLA-DR3/4 Heterozygosity is a Risk Factor for Autoantibody Conversion and Type 1 Diabetes Recurrence After Simultaneous Pancreas-Kidney Transplantation. S Diamantopoulos, G Allende, A Rosen, R Cirocco, G Ciancio, GW Burke, A Pugliese. Clinical Immunology 2007; 123: S22
Gynecomastia and Premature Thelarche: A Guide for Practitioners. Diamantopoulos S, Bao Y. Pediatrics in Review 2007; 28:e57-68
A Nine Year Old Girl with Thyrotoxicosis, Ataxia, and Chorea. Seeherunvong T, Diamantopoulos S, Berkovitz GB. Brain Dev 2007; 29:660-1
Retrospective Assessment of Islet Cell Autoantibodies in Pancreas Organ Donors. Diamantopoulos S, Allende G, Ferreira JM, Ciancio G, Burke GW, Pugliese A. Diabetes Care. 2008 ;31:1741-2
Metabolic Disease Risk in Children Born Small for Gestational Age: Catch-up Growth and Nutrition in Infancy. Myerly Kertis, Stavros Diamantopoulos. Support Line (American Dietetic Association). 2008; 30:9-13
Insulin Mutation Screening of 1044 Patients with Diabetes: Mutations in the INS Gene are a Common Cause of Neonatal Diabetes but a Rarer Cause of Diabetes Diagnosed in Childhood or Adulthood. The Neonatal Diabetes International Collaboration Group. Diabetes 2008; 57:1034-42. (participated to Neonatal Diabetes International Collaboration Group).
Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells. Vendrame F, Pileggi A, Laughlin E, Allende G, Martin-Pagola A, Molano RD, Diamantopoulos S, Standifer N, Geubtner K, Falk BA, Ichii H, Takahashi H, Snowhite I, Chen Z, Mendez A, Chen L, Sageshima J, Ruiz P, Ciancio G, Ricordi C, Reijonen H, Nepom GT, Burke GW 3rd, Pugliese A. Diabetes. 2010 Apr;59(4):947-57
Risk Factors for Type 1 Diabetes Recurrence in Immunosuppressed Recipients of Simultaneous Pancreas-Kidney Transplants. Vendrame F, Hopfner YY, Diamantopoulos S, Virdi SK, Allende G, Snowhite IV, Reijonen HK, Chen L, Ruiz P, Ciancio G, Hutton JC, Messinger S, Burke GW 3rd, Pugliese A. Am J Transplant. 2015 Aug 28. doi: 10.1111/ajt.13426.
Principal author and co-author on 3 GEC-ESTRO guidelines (Groupe Europeen de Curietherapie – European Society for Radiotherapy and Oncology)
Author and co-author of more than 70 scientific papers presented in international conferences
Author and co-author of 17 book chapters, review articles and letters to the editor
Author and co-author of more than 50 publications in prestigious journals (Total Impact Factor > 200)
Reviewer in 5 renowned international scientific peer-reviewed journals
Lecturer and faculty member in postgraduate training seminars organized by the Austrian Society for Radiation Oncology (ÖGRO), the German Society for Radiation Oncology (DGRO), the Hellenic Society for Medical Oncology (EEAO) and the Hellenic Academy of Oncology (HeSMO)
Guest lecturer in postgraduate training courses organized by the Radiation Oncology Departments of Tata Memorial Hospital, Mumbai, India, and McGill University, Canada
Guest speaker in more than 50 international conferences
Member of the GEC-ESTRO Committee
Awarded by the American Brachytherapy Society(ABS) and the Austrian Society for Radiation Oncology (ÖGRO)
2004-currently: Instructor for the annual GEC-ESTRO courses on brachytherapy for gynecologic tumors
2004-2009: Active member of the GYN GEC-ESTRO group (Gynecology Working group of the European Society for Radiotherapy and Oncology)
2005-2009: Member and coordinator of Working Group I for the contouring of the GEC ESTRO 3D GYN Brachytherapy Network
2006: Local organizer of the annual GEC-ESTRO courses on brachytherapy for gynecologic malignancies
2006-2007: Member of the Transatlantic Group for the development of cervical cancer treatment plans based on imaging data
2006-2009: Study Coordinator, Prospective Randomized Multicenter Phase III clinical study on the influence of the increase in hemoglobin levels through erythropoietin on the results of radiation therapy for cervical cancer, conducted in Austria
2007: Instructor, American Brachytherapy Society (ABS)
2008-2009: Coordinator, International Study on Magnetic Resonance Imaging (MRI)-Guided Brachytherapy in Locally Advanced Cervical Cancer (EMBRACE)
2004-2007: Senior member representative at the Austrian Society for Radiation Oncology, Radiobiology and Medical Radiation Physics (ÖGRO)
2007-2009: Senior member representative at the Austrian Society for Radiation Oncology, Radiobiology and Medical Radiation Physics (ÖGRO)
2010: Young ESTRO members’ representative at the GEC-ESTRO committee
2009: ESTRO 29 Young ESTRO members’ Advisory Committee member
2012: Course Director, International Training Course on radiotherapy for gynecologic tumors, organized by the International Atomic Energy Agency (IAEA), Metropolitan Hospital, Athens, Greece
2013: Guest speaker at the Annual Scientific Training Course on modern brachytherapy techniques under the auspices of the GEC-ESTRO
